Blog

endometriosis Seattle Women’s: Health, Research, Gynecology

Understanding Endometriosis

​Endometriosis is a pain…literally.​The condition causes tissue that normally lines the inside of the uterus to grow outside your uterus. The tissue builds up with your menstrual cycle and sheds. IWith Endometriosis the tissue cannot shed normally, and can cause internal bleeding and scarring, leading to  pain and potential fertility issues.   Other symptoms can include painful

Read More »

AJOVY FDA Approved for the Preventative Treatment of Migraines and is Now Available in Pharmacies

On September 14, 2018 the FDA approved AJOVY (fremanezumab-vfrm) injection for the preventative treatment of migraines in adults. The medication is an injectable calcitonin-gene-related peptide (CGRP) antagonist. This is the second anti-CGRP treatment that has recently been approved. This treatment is available in both quarterly and monthly injections. AJOVY can be self-administered or administered in

Read More »

FDA Approves Qbrexza Cloth for the Treatment of Hyperhidrosis

Seattle Women’s is pleased to announce that the FDA has approved a new treatment for axillary hyperhidrosis, also known as excessive underarm sweating. This is a chronic skin condition that affects approximately 10 million people in the United States and causes people to sweat more than what is necessary for normal thermal regulation. The approved

Read More »

FDA Approves New Migraine Medication

Seattle Women’s is excited to announce that the FDA has approved Aimovig, a new treatment developed specifically for migraine headache prevention. Migraine is a debilitating condition that impacts 38 million patients in the United States. Seattle Women’s conducted one of the pivotal clinical trials involved in the approval process. Aimovig is the first medication in

Read More »

FDA Approves Elagolix (Orilissa) for Endometriosis Pain

On July 24th, 2018 the US Food and Drug Administration (FDA) approved Elagolix for the treatment of moderate to severe pain associated with endometriosis. Dr. Robin Kroll, director of Seattle Women’s Health Research Gynecology has conducted over a dozen clinical trials with the newly approved endometriosis treatment, Orilissa. The drug, Elagolix — now marketed as

Read More »

“The Little Pink Pill”

This month, Flibanserin, commonly referred to as “female Viagra,” goes to the full Food and Drug Administration for a vote of approval. In early June, a federal advisory committee to the FDA recommended approval. The final vote is due on or before August 18. The entire concept of Female Sexual Dysfunction (FSD) is controversial. Does

Read More »